معرفی
Clarissa Campbell is a Principal Investigator at CeMM (Research Center for Molecular Medicine of the Austrian Academy of Sciences), having joined in July 2021. She holds a PhD in Immunology from Weill Cornell Medical College and conducted postdoctoral research under Dr. Alexander Rudensky at Memorial Sloan Kettering Cancer Center. Her work bridges immunology and metabolism, focusing on how microbial metabolites and dietary cues regulate T cell biology in the intestinal mucosa.
- Education: Biology with minor in Genetics (Federal University of Rio de Janeiro), Master’s in Immunology (Oswaldo Cruz Foundation)
Research Interests: Her group investigates:
- Integration of immunity and metabolism at organismal level
- Microbial metabolite regulation of T cell differentiation
- Systemic metabolic adaptation during helminth infections
- Host-microbe co-evolution in intestinal immune tolerance
- Application of gnotobiotic models and metabolomics
- Therapeutic exploitation of microbiota-immune interactions
Publications reveal a consistent focus on regulatory T cells, bile acid signaling, and microbiota-driven immune homeostasis across intestinal mucosa, infection models, and transplantation contexts.
Scientific Awards:
- FEBS Excellence Award for metabolic adaptation research
Grants include ERC Starting Grant and multiple FWF-funded projects on microbiomes and immune regulation. Her lab supervises postdoctoral fellows, predoctoral students, and technicians like Maximilian Baumgartner, Adrija Chakrabarty, and Elena Krstevska.
Key Collaborations involve Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, and Austrian research networks. The lab employs gnotobiotic husbandry, chemoproteomic methods, and genetic models to dissect microbe-host communication.
